MoneyWorks4Me

Samrat Pharmachem - Quaterly Results

13 Aug 2024 Evaluate
The sales figure stood at Rs. 808.24 millions for the June 2024 quarter. The mentioned figure indicates a growth of about 40.61% as compared to Rs. 574.80 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 237.97% to Rs. 20.65  millions  from Rs. 6.11 millions in previous same quarter.Operating profit for the quarter ended June 2024 rose to 31.70 millions as compared to 11.35 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 808.24 574.80 40.61 808.24 574.80 40.61 2815.81 3106.46 -9.36
Other Income 5.86 3.64 60.99 5.86 3.64 60.99 13.85 4.78 189.75
PBIDT 31.70 11.35 179.30 31.70 11.35 179.30 38.54 244.06 -84.21
Interest 1.91 2.20 -13.18 1.91 2.20 -13.18 6.87 12.32 -44.24
PBDT 29.79 9.15 225.57 29.79 9.15 225.57 31.67 231.74 -86.33
Depreciation 1.61 1.62 -0.62 1.61 1.62 -0.62 6.47 6.43 0.62
PBT 28.18 7.53 274.24 28.18 7.53 274.24 25.20 225.31 -88.82
TAX 7.53 1.42 430.28 7.53 1.42 430.28 3.57 59.00 -93.95
Deferred Tax 1.53 -0.49 -412.24 1.53 -0.49 -412.24 0.82 -2.07 -139.61
PAT 20.65 6.11 237.97 20.65 6.11 237.97 21.63 166.31 -86.99
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 3.92 1.97 98.63 3.92 1.97 98.63 1.37 7.86 -82.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..